JP2002521334A - 置換ベンズイミダゾール抗ウィルス剤 - Google Patents

置換ベンズイミダゾール抗ウィルス剤

Info

Publication number
JP2002521334A
JP2002521334A JP2000560893A JP2000560893A JP2002521334A JP 2002521334 A JP2002521334 A JP 2002521334A JP 2000560893 A JP2000560893 A JP 2000560893A JP 2000560893 A JP2000560893 A JP 2000560893A JP 2002521334 A JP2002521334 A JP 2002521334A
Authority
JP
Japan
Prior art keywords
alkyl
ylmethyl
embedded image
benzimidazol
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
JP2000560893A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002521334A5 (enExample
Inventor
クオ ロング ユー
リタ リー シヴィエロ
マーク アール クリスタル
キャスリーン エフ カドー
ニコラス エイ ミーンウェル
Original Assignee
ブリストルーマイヤーズ スクイブ カンパニー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ブリストルーマイヤーズ スクイブ カンパニー filed Critical ブリストルーマイヤーズ スクイブ カンパニー
Publication of JP2002521334A publication Critical patent/JP2002521334A/ja
Publication of JP2002521334A5 publication Critical patent/JP2002521334A5/ja
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
JP2000560893A 1998-07-20 1999-07-20 置換ベンズイミダゾール抗ウィルス剤 Abandoned JP2002521334A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9338798P 1998-07-20 1998-07-20
US60/093,387 1998-07-20
PCT/US1999/012398 WO2000004900A1 (en) 1998-07-20 1999-07-20 Substituted benzimidazole antiviral agents

Publications (2)

Publication Number Publication Date
JP2002521334A true JP2002521334A (ja) 2002-07-16
JP2002521334A5 JP2002521334A5 (enExample) 2006-08-17

Family

ID=22238648

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000560893A Abandoned JP2002521334A (ja) 1998-07-20 1999-07-20 置換ベンズイミダゾール抗ウィルス剤

Country Status (6)

Country Link
US (2) US6908936B2 (enExample)
EP (1) EP1098644A1 (enExample)
JP (1) JP2002521334A (enExample)
AU (1) AU741946B2 (enExample)
CA (1) CA2338147A1 (enExample)
WO (1) WO2000004900A1 (enExample)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008528564A (ja) * 2005-01-31 2008-07-31 アロウ セラピューティクス リミテッド 抗ウイルス剤としてのキナゾリン誘導体
JP2011503136A (ja) * 2007-11-15 2011-01-27 エフ．ホフマン−ラ ロシュ アーゲー ベンゾイミダゾール誘導体及びｆｘｒアゴニストとしてのその使用
JP2020532494A (ja) * 2017-07-20 2020-11-12 アールイーヴァイラル リミテッド 医薬化合物

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003503403A (ja) 1999-06-28 2003-01-28 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 呼吸合胞体ウイルス複製阻害剤
CA2407292A1 (en) * 2000-05-03 2001-11-08 Medimmune, Inc. Combination therapy of respiratory diseases using antibodies and anti-inflammatory agents
US6489338B2 (en) * 2000-06-13 2002-12-03 Bristol-Myers Squibb Company Imidazopyridine and imidazopyrimidine antiviral agents
US6506738B1 (en) 2000-09-27 2003-01-14 Bristol-Myers Squibb Company Benzimidazolone antiviral agents
US6774134B2 (en) 2000-12-20 2004-08-10 Bristol-Myers Squibb Company Heterocyclic substituted 2-methyl-benzimidazole antiviral agents
US20040096451A1 (en) * 2002-07-25 2004-05-20 Young James F. Methods of treating and preventing RSV, hMPV, and PIV using anti-RSV, anti-hMPV, and anti-PIV antibodies
US7030150B2 (en) * 2001-05-11 2006-04-18 Trimeris, Inc. Benzimidazole compounds and antiviral uses thereof
US6919331B2 (en) * 2001-12-10 2005-07-19 Bristol-Myers Squibb Company Substituted 2-methyl-benzimidazole respiratory syncytial virus antiviral agents
US7157471B2 (en) * 2003-08-25 2007-01-02 Boehringer Ingelheim International Gmbh Haloalkyl- and piperidine-substituted benzimidazole-derivatives
WO2005042530A1 (en) 2003-10-30 2005-05-12 Boehringer Ingelheim (Canada) Ltd. Rsv polymerase inhibitors
GB0406282D0 (en) * 2004-03-19 2004-04-21 Arrow Therapeutics Ltd Therapeutic compounds
GB0406280D0 (en) * 2004-03-19 2004-04-21 Arrow Therapeutics Ltd Chemical compounds
CA2622592A1 (en) 2005-09-19 2007-03-29 Arrow Therapeutics Limited Benzodiazepine derivatives for treating hepatitis c infection
GB0520475D0 (en) * 2005-10-07 2005-11-16 Arrow Therapeutics Ltd Chemical compounds
ATE508125T1 (de) * 2006-01-11 2011-05-15 Arrow Therapeutics Ltd Triazoloanilinopyrimidinderivate zur verwendung als antivirale mittel
CA2698075C (en) * 2007-08-27 2016-04-12 Siga Technologies, Inc. Antiviral drugs for treatment of arenavirus infection
RU2407738C1 (ru) * 2009-07-03 2010-12-27 Общество с ограниченной ответственностью "Интеллектуальный Диалог" Противовирусный активный компонент, фармацевтическая композиция, лекарственное средство, способ лечения вирусных заболеваний
US9850251B2 (en) 2013-12-10 2017-12-26 Shandong Danhong Pharmaceutical Co., Ltd. Imidazole derivative used as antiviral agent and use therof in preparation of medicament
WO2016197908A1 (zh) 2015-06-08 2016-12-15 南京明德新药研发股份有限公司 咪唑衍生物及其中间体的制备方法和晶型
CN105820156A (zh) * 2016-04-21 2016-08-03 广东工业大学 苯并三氮唑基苯并咪唑啉及其制备方法和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3394141A (en) 1965-11-12 1968-07-23 Fabio Sparatore Z-benzyaminobenzimidazoles
US4324794A (en) * 1980-08-26 1982-04-13 Research Triangle Institute Inhibition of respiratory syncytial virus-induced cell fusion by amidino compounds
NO155805C (no) 1981-02-06 1987-06-10 Ucb Sa Analogifremgangsmaate for fremstilling av terapeutisk virksomme 2-(4-(difenylmethyl)-1-piperazinyl)-eddiksyrer og deres amider og ikke-toksiske salter.
US5066656A (en) * 1989-11-01 1991-11-19 Janssen Pharmaceutica N.V. Pharmacologically active (6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-5-yl)- and (5,6,7,8-tetrahydroimidazo[1,5-a]pyridin-5-yl) substituted 1H-benzotriazole derivatives
US5256668A (en) 1993-03-17 1993-10-26 American Home Products Corporation Aminopyrimidine derivatives as antiviral agents for respiratory syncytial virus
ZA971185B (en) 1996-02-13 1998-08-12 American Cyanamid Co Triazine containing compounds useful as antiviral agents
US6919331B2 (en) * 2001-12-10 2005-07-19 Bristol-Myers Squibb Company Substituted 2-methyl-benzimidazole respiratory syncytial virus antiviral agents

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008528564A (ja) * 2005-01-31 2008-07-31 アロウ セラピューティクス リミテッド 抗ウイルス剤としてのキナゾリン誘導体
JP2011503136A (ja) * 2007-11-15 2011-01-27 エフ．ホフマン−ラ ロシュ アーゲー ベンゾイミダゾール誘導体及びｆｘｒアゴニストとしてのその使用
JP2020532494A (ja) * 2017-07-20 2020-11-12 アールイーヴァイラル リミテッド 医薬化合物

Also Published As

Publication number Publication date
US6908936B2 (en) 2005-06-21
US20050038085A1 (en) 2005-02-17
AU741946B2 (en) 2001-12-13
EP1098644A1 (en) 2001-05-16
AU5080999A (en) 2000-02-14
US20030139450A1 (en) 2003-07-24
US7030140B2 (en) 2006-04-18
CA2338147A1 (en) 2000-02-03
WO2000004900A1 (en) 2000-02-03

Similar Documents

Publication Publication Date Title
US6506738B1 (en) Benzimidazolone antiviral agents
US6774134B2 (en) Heterocyclic substituted 2-methyl-benzimidazole antiviral agents
US20030139450A1 (en) Substituted benzimidazole antiviral agents
TWI423963B (zh) 可用於治療ｃ型肝炎之化合物之合成方法
US6489338B2 (en) Imidazopyridine and imidazopyrimidine antiviral agents
JP2868313B2 (ja) Ｎ−置換複素環誘導体およびその製法
US5866589A (en) Alkyl substituted piperadinyl and piperazinyl anti-AIDS compounds
DE60008372T2 (de) Pharmazeutisch aktive verbindungen
EP1142879B1 (en) Imidazole compounds and medicinal use thereof
FI100969B (fi) Menetelmä valmistaa terapeuttisesti aktiivista pyratsolo£1,5-a|pyridii niyhdistettä
CZ285799B6 (cs) Indolové deriváty, způsob jejich výroby, jejich použití pro výrobu farmaceutických prostředků a farmaceutické prostředky s jejich obsahem
CZ296163B6 (cs) Karboxyamidy chinolinu jako inhibitory TNF a inhibitory PDE-IV
SK287919B6 (sk) Indolylmaleimide derivatives, method for the preparation thereof and pharmaceutical composition comprising same
KR20150033645A (ko) 호흡기 합포체 바이러스의 항바이러스제로서의 벤즈이미다졸로 치환된 1,3-디하이드로-2h-벤즈이미다졸-2-온 유도체
TW201307341A (zh) 作為呼吸道融合病毒抗病毒劑之咪唑并吡啶類
JP2010513386A5 (enExample)
HUT74678A (en) Imidazo[1,2-a]pyrazine-4-one, preparation thereof and drugs containing same
HU203345B (en) Process for producing ergoline derivatives and pharmaceutical compositions comprising same
JPWO1997000258A1 (ja) 三環性ベンゾアゼピン化合物
CN101142208B (zh) 作为呼吸道合胞病毒复制抑制剂的1,3-二氢-苯并咪唑-2-亚基胺
FI107155B (fi) Menetelmä farmakologisesti käyttökelpoisten 1-(imidatso[1,2-a]pyridin-6-yyli)-sykloheksaanikarbotioamidijohdannaisten valmistamiseksi
US5624948A (en) 1-(2-benzimidazolyl)-1,5-diazacyclooctane compounds
HK1214244A1 (zh) 咪唑并吡啶衍生物
US20030207876A1 (en) 3-Azabicyclo[3.1.0]hexane derivatives useful in therapy
JP4611026B2 (ja) イミダゾリル化合物の製造のための新規な方法

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20060622

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20060622

A762 Written abandonment of application

Free format text: JAPANESE INTERMEDIATE CODE: A762

Effective date: 20061221